The FDA's New Psychedelic Rules Are Groovy, but the Agency Is Still a Bad Trip (opens in new tab)
The new rules will fast track clinical testing, but a far cry from legalization or decriminalization.
Read the original articleThe new rules will fast track clinical testing, but a far cry from legalization or decriminalization.
Read the original article